Literature DB >> 9895242

Is pseudoexfoliation syndrome inherited? A review of genetic and nongenetic factors and a new observation.

K F Damji1, H S Bains, E Stefansson, M Loftsdottir, T Sverrisson, E Thorgeirsson, F Jonasson, M Gottfredsdottir, R R Allingham.   

Abstract

Pseudoexfoliation (PEX) syndrome is the commonest identifiable cause of open-angle glaucoma worldwide. PEX is characterized clinically by small whitish deposits of fibrillar-granular material in the anterior segment of the eye. Despite its prevalence and potential for ophthalmic morbidity, surprisingly little is known about the etiology and pathogenesis of PEX. This article reviews the literature and presents evidence regarding genetic and nongenetic arguments for the etiology of pseudoexfoliation. Lines of evidence that support a genetic basis for PEX include transmission in two-generation families, twin studies, an increased risk of PEX in relatives of affected patients, and HLA studies. Nearly all pedigrees in the literature, and our own experience with PEX families in Iceland and Canada, suggest maternal transmission, raising the possibilities of mitochondrial inheritance, X-linked inheritance, and autosomal inheritance with genomic imprinting. A number of nongenetic factors have also been evaluated for their possible implication in the development of PEX. These include ultraviolet light, autoimmunity, slow virus infection, and trauma. It is possible that a combination of genetic and nongenetic factors may be involved in the etiology and pathogenesis of PEX, i.e. it may be a multifactorial disorder. Further studies with larger numbers of patients are needed to delineate more clearly the contribution of genetic (nuclear DNA, mitochondrial DNA or both) and nongenetic factors to the development of pseudoexfoliation syndrome and pseudoexfoliation glaucoma.

Entities:  

Mesh:

Year:  1998        PMID: 9895242     DOI: 10.1076/opge.19.4.175.2310

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN: 1381-6810            Impact factor:   1.803


  31 in total

1.  Serum YKL-40 levels as a novel marker of inflammation and endothelial dysfunction in patients with pseudoexfoliation syndrome.

Authors:  K Türkyılmaz; V Öner; A Kırbas; M S Sevim; B Sekeryapan; G Özgür; M Durmus
Journal:  Eye (Lond)       Date:  2013-05-10       Impact factor: 3.775

2.  LOXL1 gene analysis in Turkish patients with exfoliation glaucoma.

Authors:  Suzan Guven Yilmaz; Melis Palamar; Huseyin Onay; Orhan Ilim; Ayca Aykut; Feristah Ferda Ozkinay; Ayse Yagci
Journal:  Int Ophthalmol       Date:  2016-01-13       Impact factor: 2.031

Review 3.  Exfoliation syndrome in sub-Saharan Africa.

Authors:  Olusola O Olawoye; Louis R Pasquale; Robert Ritch
Journal:  Int Ophthalmol       Date:  2014-05-21       Impact factor: 2.031

4.  Pseudoexfoliation syndrome in Icelandic families.

Authors:  R R Allingham; M Loftsdottir; M S Gottfredsdottir; E Thorgeirsson; F Jonasson; T Sverisson; W G Hodge; K F Damji; E Stefánsson
Journal:  Br J Ophthalmol       Date:  2001-06       Impact factor: 4.638

5.  [Cataract patients with pseudoexfoliation (PEX) syndrome among a population with high prevalence of PEX. Clinical findings and morphological and surgical characteristics].

Authors:  A A Bialasiewicz; U Wali; R Shenoy; R Al-Saeidi
Journal:  Ophthalmologe       Date:  2005-12       Impact factor: 1.059

6.  Alzheimer's peptide and serine proteinase inhibitors in glaucoma and exfoliation syndrome.

Authors:  Sabina Janciauskiene; Torsten Krakau
Journal:  Doc Ophthalmol       Date:  2003-05       Impact factor: 2.379

7.  Gene therapy in glaucoma-part I: Basic mechanisms and molecular genetics.

Authors:  Mohamed A E Soliman Mahdy
Journal:  Oman J Ophthalmol       Date:  2010-01

8.  The prevalence of pseudoexfoliation syndrome in Chinese people.

Authors:  A L Young; W W T Tang; D S C Lam
Journal:  Br J Ophthalmol       Date:  2004-02       Impact factor: 4.638

9.  Review: The role of LOXL1 in exfoliation syndrome/glaucoma.

Authors:  Benjamin T Whigham; R Rand Allingham
Journal:  Saudi J Ophthalmol       Date:  2011-07-27

10.  Evaluation of LOXL1 polymorphisms in exfoliation syndrome in a Chinese population.

Authors:  Ling Chen; Liyun Jia; Ningli Wang; Guangxian Tang; Chun Zhang; Sujie Fan; Wenru Liu; Hailin Meng; Wotan Zeng; Ningpu Liu; Huaizhou Wang; Hongyan Jia
Journal:  Mol Vis       Date:  2009-11-14       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.